S. Louise Phanstiel Myriad Genetics Inc (MYGN) insider trading activity

S. Louise Phanstiel is Director of MYRIAD GENETICS INC. Currently has a direct ownership of 177,444 shares of MYGN, which is worth approximately $1.4 Million. The most recent transaction as insider was on Jun 05, 2025, when has been sold 49,796 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 177K

0% 3M change

39.01% 12M change

Total Value Held $1.4 Million

S. Louise Phanstiel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2025	BUY Grant, award, or other acquisition	-	49,796 Added 21.91%	177,444 Common Stock
Jun 06 2024	BUY Grant, award, or other acquisition	-	15,695 Added 10.95%	127,648 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	-	15,151 Added 11.92%	111,953 Common Stock
Jun 02 2022	BUY Grant, award, or other acquisition	-	17,275 Added 15.14%	96,802 Common Stock
Aug 05 2021	SELL Open market or private sale	$1,677,750 $35.04 p/Share	47,881 Reduced 43.72%	61,646 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	$1,400,400 $23.34 p/Share	60,000 Added 39.57%	91,646 Common Stock
Jun 03 2021	BUY Grant, award, or other acquisition	-	12,848 Added 13.91%	79,527 Common Stock
Dec 04 2020	BUY Grant, award, or other acquisition	-	15,889 Added 16.12%	82,679 Common Stock
Nov 11 2020	BUY Open market or private purchase	$249,300 $16.62 p/Share	15,000 Added 18.34%	66,790 Common Stock

Also insider at

BFLY

Butterfly Network, Inc. Healthcare

Director

SLP